Hedyotis diffusa Willd suppresses metastasis in 5‑fluorouracil‑resistant colorectal cancer cells by regulating the TGF‑β signaling pathway
- PMID: 28944846
- DOI: 10.3892/mmr.2017.7500
Hedyotis diffusa Willd suppresses metastasis in 5‑fluorouracil‑resistant colorectal cancer cells by regulating the TGF‑β signaling pathway
Abstract
Colorectal cancer (CRC) is one of the most common malignant tumors of the digestive tract, and threatens the survival and health of patients with CRC. Chemotherapy remains one of the main therapeutic approaches for patients with CRC; however, drug resistance limits the long‑term use. CRC cells with multi‑drug resistance (MDR) exhibit increased survival times and metastatic potential, which may lead to the recurrence and metastasis of CRC. In addition, MDR is one of the major causes of chemotherapy failure in clinical treatment. Hedyotis diffusa Willd (HDW) has been used in the treatment of inflammation‑associated diseases and malignant tumors, including CRC. The authors previously demonstrated that HDW could reverse MDR in CRC cells; however, its underlying mechanism, particularly in MDR‑associated metastasis, remains to be elucidated. In the present study, the drug‑resistant CRC cell line HCT‑8/5‑fluorouracil (5‑FU) was used to investigate the effect of HDW on the growth and metastasis of cancer cells. Cell viability was assessed using the MTT assay. Cell adhesion potential was evaluated using adhesion experiments. Cell migration was assessed using wound healing and Transwell assays. The mRNA and protein expression levels of crucial factors in the transforming growth factor‑β (TGF‑β) signaling pathway, including TGF‑β, Mothers against decapentaplegic homolog 4 (SMAD4), neural (N)‑cadherin, and epithelial (E)‑cadherin, were analyzed using the reverse transcription‑semi‑quantitative polymerase chain reaction and western blotting, respectively. The results demonstrated that the HCT‑8/5‑FU cell line was more resistant to 5‑FU and thus can be used as the resistant cell model. HDW was able to inhibit the viability, and adhesive, migratory and invasion potential of the HCT‑8/5‑FU cells. In addition, HDW was able to downregulate the expression of TGF‑β, SMAD4 and N‑cadherin, and upregulate E‑cadherin, at the gene and protein level. In conclusion, the results demonstrated that HDW may suppress the metastasis of 5‑FU‑resistant CRC cells via regulation of the TGF‑β signaling pathway, which was also considered to be one of the underlying mechanisms of its anti‑CRC effect.
Similar articles
-
Hedyotis diffusa Willd inhibits proliferation and induces apoptosis of 5‑FU resistant colorectal cancer cells by regulating the PI3K/AKT signaling pathway.Mol Med Rep. 2018 Jan;17(1):358-365. doi: 10.3892/mmr.2017.7903. Epub 2017 Oct 26. Mol Med Rep. 2018. PMID: 29115462
-
The anti-tumor effect and bioactive phytochemicals of Hedyotis diffusa willd on ovarian cancer cells.J Ethnopharmacol. 2016 Nov 4;192:132-139. doi: 10.1016/j.jep.2016.07.027. Epub 2016 Jul 15. J Ethnopharmacol. 2016. PMID: 27426510
-
Investigating the Multi-Target Pharmacological Mechanism of Hedyotis diffusa Willd Acting on Prostate Cancer: A Network Pharmacology Approach.Biomolecules. 2019 Oct 9;9(10):591. doi: 10.3390/biom9100591. Biomolecules. 2019. PMID: 31600936 Free PMC article.
-
Antitumor potential of Hedyotis diffusa Willd: A systematic review of bioactive constituents and underlying molecular mechanisms.Biomed Pharmacother. 2020 Oct;130:110735. doi: 10.1016/j.biopha.2020.110735. Epub 2020 Sep 12. Biomed Pharmacother. 2020. PMID: 34321173
-
Molecular Mechanism of Anti-Colorectal Cancer Effect of Hedyotis diffusa Willd and Its Extracts.Front Pharmacol. 2022 Jun 2;13:820474. doi: 10.3389/fphar.2022.820474. eCollection 2022. Front Pharmacol. 2022. PMID: 35721163 Free PMC article. Review.
Cited by
-
Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance.NPJ Precis Oncol. 2024 Feb 10;8(1):31. doi: 10.1038/s41698-024-00522-z. NPJ Precis Oncol. 2024. PMID: 38341519 Free PMC article. Review.
-
Bufalin targets the SRC-3/c-Myc pathway in chemoresistant cells to regulate metastasis induced by chemoresistance in colorectal cancer.J Cancer Res Clin Oncol. 2025 Feb 8;151(2):71. doi: 10.1007/s00432-025-06124-x. J Cancer Res Clin Oncol. 2025. PMID: 39921753 Free PMC article.
-
Qingjie Fuzheng Granule Inhibited the Migration and Invasion of Colorectal Cancer Cells by Regulating the lncRNA ANRIL/let-7a/TGF-β1/Smad Axis.Evid Based Complement Alternat Med. 2020 Jun 29;2020:5264651. doi: 10.1155/2020/5264651. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32714407 Free PMC article.
-
miR-361 enhances sensitivity to 5-fluorouracil by targeting the FOXM1-ABCC5/10 signaling pathway in colorectal cancer.Oncol Lett. 2019 Oct;18(4):4064-4073. doi: 10.3892/ol.2019.10741. Epub 2019 Aug 14. Oncol Lett. 2019. PMID: 31579069 Free PMC article.
-
TGF-β Signaling in Metastatic Colorectal Cancer (mCRC): From Underlying Mechanism to Potential Applications in Clinical Development.Int J Mol Sci. 2022 Nov 20;23(22):14436. doi: 10.3390/ijms232214436. Int J Mol Sci. 2022. PMID: 36430910 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous